ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LXEO Lexeo Therapeutics Inc

8.66
-0.25 (-2.81%)
27 Sep 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)
Total Revenue 000
Operating Income -14.97M-23.29M-23.55M
Pre Tax Income -14.19M-21.68M-21.24M
Net Income -14.19M-21.68M-21.24M
Preferred Dividends 000
Basic Earnings Per Share (EPS) 000
EBIT -15.24M-23.3M-23.55M
EBITDA -14.9M-23.22M-23.47M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 1.66M654k0
Operating Income -50.64M-60.51M-68.51M
Pre Tax Income -50.62M-59.28M-66.39M
Net Income -50.62M-59.28M-66.39M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -3.023-3.481-40.658
EBIT -50.64M-60.51M-69.06M
EBITDA -50.62M-60.39M-68.24M

Your Recent History

Delayed Upgrade Clock